GlobeNewswire by notified

Hot Silicon Valley Tech Firm Grows in Krakow

Share

SignalFx Opens Research and Development and Support Office;
Hires Industry Veteran Martin Burlinski, Head of Engineering, EMEA

SAN MATEO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring for infrastructure, microservices, and applications, is announcing the opening of a new Research, Development and Support Office in Krakow, Poland and the addition of Martin Burlinski, Head of Engineering, EMEA.  The new Krakow facility will enable SignalFx to accelerate product development and provide broader global support for its customers.

“We were naturally attracted to Krakow not only because of its strong existing talent pool of world-class engineers but also its proximity to recent graduates from the city’s many universities,” said Leonid Igolnik, EVP Engineering for SignalFx.  “We have an immediate need for engineers to become a core part of our company working side-by-side with our Silicon Valley and Research Triangle Park teams.  With a global client base and the industry’s only streaming analytics, NoSample™ architecture we need to continually push the boundaries of what’s technically possible to operate in a real-time world.”

SignalFx offers a highly differentiated and technically advanced monitoring platform optimized for today’s increasingly complex cloud-native environments. It incorporates innovations like end-to-end streaming analytics that finds problems in real time, and a NoSample™ architecture based distributed tracing solution that observes every single transaction and isolates all outliers instead of just a small subset. Innovations such as these help developers rapidly spot issues and initiate fixes before they impact customers.

“It’s critical that our customer service meets the real-time demands businesses face,” said Matt Stone, Director Global Technical Support, SignalFx.  “Our new Krakow facility dramatically expands our time zone coverage, supporting our rapidly growing EMEA and APAC markets, and takes us toward a 24/7 model.”

SignalFx has immediate openings in Krakow for the following positions:

  • Software Engineering
  • System Testing
  • Production Engineering
  • Customer Success Engineering
  • Technical Support
  • Cloud Security

“We are opening an office in Krakow that will not only do cutting-edge work but also will evoke the cool look and feel of what you might find in California,” said Burlinski.  “Our engineers will feel immersed both in the work and culture of Silicon Valley.”

Mr. Burlinski brings experience from building some of the largest business-to-business software-as-a-service products in the world with companies like Taleo and Oracle and has extensive product development experience in Canada, Silicon Valley and Poland.  Most recently at Oracle, Mr. Burlinski grew the Krakow office from a small team to a sizable multi-disciplinary organization.

About SignalFx
SignalFx is the only real-time cloud monitoring platform for infrastructure, microservices, and applications.  The platform collects metrics and traces across every component in your cloud environment, replacing traditional point tools with a single integrated solution that works across the stack.  SignalFx is built on a massively scalable streaming architecture that applies advanced predictive analytics for real-time problem detection. With its NoSample™ distributed tracing capabilities, SignalFx reliably monitors all transactions across microservices, accurately identifying all anomalies.  And through data-science-powered directed troubleshooting SignalFx guides the operator to find the root cause of issues in seconds.  SignalFx is used by leading enterprises across high tech, financial services, consumer products, retail, communications, media, entertainment and web-scale players like Yelp, HubSpot, Acquia and Kayak.  SignalFx is venture-funded by Andreessen Horowitz, Charles River Ventures, and General Catalyst.

Kristen Caron
Kristen.caron@aircoverpr.com
978-407-9283

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Handelsinvest opdaterer prospektet23.4.2024 11:22:23 CEST | pressemeddelelse

Investeringsforeningen Handelsinvest Vestergade 8-16 8600 Silkeborg Tlf. 8989 2500 handelsinvest@jyskeinvest.dk www.handelsinvest.dk Nasdaq Copenhagen A/S Nikolaj Plads 6 1007 København K23. april 2024 Opdatering af prospektet i Handelsinvest Investeringsforeningen Handelsinvest har opdateret prospektet. Der er sket følgende opdateringer/ændringer: Opdatering af data på bestyrelsesmedlemmer.Tilføjelse af ”under overflytning” og ”under fusion” i de afdelingsspecifikke afsnit.Opdatering af investeringsstrategien i afdeling Nordamerika.Sproglige tilpasninger m.m. Det opdaterede prospekt kan findes på www.handelsinvest.dk Med venlig hilsen Lone Mørch Henrik Kragh Bestyrelsesformand Director

CDR-Life to Present Tumor Targeting Capabilities of M-gager® Platform at the TCR-Based Therapies for Solid Tumors Summit23.4.2024 11:00:00 CEST | Press release

ZÜRICH, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced a presentation on its proprietary antibody-major histocompatibility complex (MHC) technology for the development of highly specific T-cell engagers (TCE) at the TCR-Based Therapies for Solid Tumors Summit, occurring April 23-25 in Boston, Massachusetts. The presentation will discuss how antibodies targeting tumor peptides on the MHC enable T-cells access to an untapped reservoir of intracellular tumor antigens and will highlight the M-gager® technology’s ability to leverage the potency, versatility and manufacturability of antibodies to revolutionize cancer immunotherapy. Presentation Details Title: Unlocking Tumor Eradication with Antibody-MHC T Cell Engagers Presenter: Leonardo Borras, Chief Scientific Officer Date: April 23, 2024 About CDR-Life CDR-Life is developing powerful T-cell engagers (TCE) to eradicate hard-to-treat solid tumors. Our integrated antibody-based TCE platform unlocks access to

Planlagt suspension i Sparinvest SICAV23.4.2024 10:54:57 CEST | pressemeddelelse

København, April 23, 2024 (GLOBE NEWSWIRE) -- Det skal oplyses, at der grundet lokale børslukkedage i underliggende markeder vil være suspension af nedenstående afdelinger onsdag d. 1 maj 2024. Fund nameISINOrder book codeEquitas EUR RLU0362354549SSIEEURREthical Global Value EUR RLU0362355355SSIEGVEURREuropean Value EUR RLU0264920413SSIEUVEURRGlobal Value EUR RLU0138501191SSIGVEURR Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit eller Christian Rye Holm, CRH@nykredit.dk. Med venlig hilsen ID-Sparinvest, Filial af Sparinvest S.A, Luxembourg Dirk Schulze

Planlagt suspension i Investeringsforeningen Sparinvest23.4.2024 10:52:33 CEST | pressemeddelelse

Det skal oplyses, at der grundet lokale børslukkedage i underliggende markeder vil være suspension af nedenstående afdelinger onsdag d. 1 maj 2024. Fund nameISINOrder book codeMix Aktier KL ADK0010014778SPIMAKLAValue Aktier KL ADK0010079631SPIVAKLAValue Europa KL ADK0060032571SPIVEUKLAValue Emerging Markets KL ADK0010304856SPIVEMKLABæredygtige Aktier Akk. KL ADK0060012896SPIBDAAKKKLAINDEX Dow Jones Sustainability World KLDK0010297464SPIDJWKLINDEX Emerging Markets KLDK0060300762SPIEMIKLINDEX Europa Growth KLDK0010297548SPIEUGKLINDEX Europa Small Cap KLDK0010297621SPIEUCKLINDEX Europa Value KLDK0010297704SPIEUVKLBæredygtige Aktier KL ADK0061294048SPIBDAGlobale Fokusaktier KL ADK0061293826SPIGFAMix Maksimum Risiko KL ADK0061551892SPIMMRIABæredygtige Value Aktier KL ADK0061551546SPIBDVAAMix Lav Risiko KL ADK0060623189SPIMLRKLAMix Mellem Risiko KL ADK0060623262SPIMMRKLAMix Høj Risiko KL ADK0060623346SPIMHRKLAMix Minimum Risiko KL ADK0060914901SPIMIXMINRISKKLA Eventuelle spørgsmål vedrørende

Delårsrapport for perioden 1. januar - 31. marts 202423.4.2024 10:47:40 CEST | pressemeddelelse

Bestyrelsen for Tivoli A/S har den 23. april 2024 behandlet og godkendt delårsrapporten for perioden 1. januar - 31. marts 2024. Tivoli åbnede sommersæsonen 22. marts, hvilket er tidligere end sidste år hvor sæsonen åbnede 31. marts. Dette påvirker resultatet for perioden som i hovedtræk er: En nettoomsætning på 90,4 mio. kr. mod 61,8 mio. kr. sidste år (+46%).Et resultat før af- og nedskrivninger (EBITDA) på -84,2 mio. kr. mod -96,7 mio. kr. sidste år.Et resultat før skat på -112,4 mio. kr. mod -126,1 mio. kr. sidste år.Et besøgstal på 221.000 mod 47.000 sidste år (+470%). ”Tivoli fortsætter den positive udvikling, vi så i 2023. Første kvartal 2024 tegner sig for et resultat svarende til det forventede, med bedre gæstetal og økonomisk resultat, end samme periode i 2023. Vi går ind i sommersæsonen med optimisme og en lang række attraktive tilbud til Tivolis gæster, som bl.a. kan se frem til en sommer med et overordentlig stærkt kulturprogram.” udtaler adm. direktør, Susanne Mørch Koch

HiddenA line styled icon from Orion Icon Library.Eye